SHARE CAPITAL DEVELOPMENT

Since Xbrane Biopharma was formed in 2008, the share capital has changed according to what is indicated by the table below.

Date Transaction Change number of shares Total number of shares Change share capital Total share capital
2017-09-25
New share issue
16,500 5,956,770 3,699 1,335,425
2017-06-16 Conversion of convertible loan 528,986 5,940,270 118,591 1,331,725
2017-06-05 New share issue 655,738 5,411,284 147,007 1,213,134
2016-10-31 Conversion of convertible loan 132,232 4,755,546 29,644 1,066,127
2016-01-22 New share issue 2,393,024 4,623,314 536,483 1,036,483
2015-12-02 Bonus issue 2,230,290 399,100 500,000
2015-12-02 Split 10:1 2,230,290 100,899
2015-03-11 New share issue 1,989 223,029 900 100,899
2014-02-10 Split 10:1 221,040 100,000
2014-02-10 New share issue 11,052 22,104 50,000 100,000
2013-07-22 Share capital decrease approval 50,000
2013-05-15 Share capital decrease 11,052 -355,200 50,000
2013-04-25 Share capital decrease 11,052 -700,000 405,200
2013-04-25 New share issue 9,824 11,052 982,400 1,105,200